148 related articles for article (PubMed ID: 30301396)
1. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
[TBL] [Abstract][Full Text] [Related]
2. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
3. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
Rekhi B; Basak R; Desai SB; Jambhekar NA
Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
[TBL] [Abstract][Full Text] [Related]
5. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma.
Atef A; Alrashidy M
Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872
[TBL] [Abstract][Full Text] [Related]
6. TLE1 expression fails to distinguish between synovial sarcoma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans.
Pukhalskaya T; Smoller BR
J Cutan Pathol; 2020 Feb; 47(2):135-138. PubMed ID: 31614009
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
8. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
Bakrin IH; Hussain FA; Tuan Sharif SE
Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
[TBL] [Abstract][Full Text] [Related]
9. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
[TBL] [Abstract][Full Text] [Related]
11. Frequent TLE1 Expression in Cutaneous Neoplasms.
Xiong Y; Dresser K; Cornejo KM
Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
13. TLE1 Expression in Malignant Rhabdoid Tumor and Atypical Teratoid/Rhabdoid Tumor.
Duncan VE; Wicker JA; Kelly DR; Li R
Pediatr Dev Pathol; 2018; 21(6):522-527. PubMed ID: 29490565
[TBL] [Abstract][Full Text] [Related]
14. Expression of TLE1 in a Carcinoid Tumor of the Lung With Spindle Cell Morphology-A Potential Diagnostic Pitfall.
Jeffus SK; Meena N; Lindberg M
Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):644-647. PubMed ID: 37668410
[TBL] [Abstract][Full Text] [Related]
15. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas.
Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR
Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579
[TBL] [Abstract][Full Text] [Related]
16. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
17. TLE1 expression in malignant mesothelioma.
Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
[TBL] [Abstract][Full Text] [Related]
18. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.
Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY
Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Utility of TLE1 (Transducer-Like Enhancer of Split 1) in Distinguishing Synovial Sarcoma from Mimicking Tumors.
Qureshi MB; Tariq MU; Abdul-Ghafar J; Chundriger Q; Ud Din N
Int J Gen Med; 2021; 14():9173-9179. PubMed ID: 34880656
[TBL] [Abstract][Full Text] [Related]
20. Is TLE1 Expression Limited to Synovial Sarcoma? Our Experience at Shifa International Hospital, Pakistan.
Ali Z; Haroon Khan A; Rehman U; Faisal M; Ahmad IN; Mamoon N; Nasir H; Hameed Z
Cureus; 2019 Nov; 11(11):e6259. PubMed ID: 31893185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]